Different Modes of Peptide Interaction Enable HLA-DQ and HLA-DR Molecules to Bind Diverse Peptide Repertoires

Journal of Immunology

Volumn 159, Issue 2, 1997, Pages 703-711

  Raddrizzani, Laura ^a   Sturniolo, Tiziana ^a   Guenot, Jeanmarie ^b   Bono, Elisa ^a   Gallazzi, Fabio ^a   Nagy, Zoltan A ^b   Sinigaglia, Francesco ^a   Hammer, Juergen ^a  

^a ROCHE MILANO RICERCHE   (Italy)

^b HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN; PEPTIDE;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ARTICLE; CHEMISTRY; HUMAN; IMMUNOLOGY; MOLECULAR GENETICS; PROTEIN BINDING;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING;

EID: 0031570937     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Germain, R. N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287.
2. Hammer, J. 1995. New methods to predict MHC-binding sequences within protein antigens. Curr. Opin. Immunol. 7:263.
3. Hammer, J., T. Sturniolo, and F. Sinigaglia. HLA class II peptide binding specificity and autoimmunity. Adv. Immunol. In press.
4. Brown, J. H., T. S. Jardetzky, J. C. Gorga, L. J. Stern, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1993. The three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33.
5. Stern, L. J., J. H. Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an Influenza virus peptide. Nature 368:215.
6. Ghosh, P., M. Amaya, E. Mellins, and D. C. Wiley. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378:457.
7. Sette, A., S. Buus, S. Colon, J. A. Smith, C. Miles, and H. M. Grey. 1987. Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells. Nature 328:395.
8. Rothbard, J. B., and M. L. Gefter. 1991. Interaction betwenn immunogenic peptides and MHC proteins. Annu. Rev. Immunol. 9:527.
9. Hammer, J., P. Valsasnini, K. Tolba, D. Bolin, J. Higelin, B. Takacs, and F. Sinigaglia. 1993. Promiscuous and allele-specific anchors in HLA-DR binding peptides. Cell 74:197.
10. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1991. Allele specific motifs revealed by sequencing of self peptides eluted from MHC molecules. Nature 351:290.
11. Hammer, J., C. Belunis, D. Bolin, J. Papadopoulos, R. Walsky, J. Higelin, W. Danho, F. Sinigaglia, and Z. A. Nagy. 1994. High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. Proc. Natl. Acad. Sci. USA 91:4456.
12. Jardetzky, T. S., J. C. Gorga, R. Busch, J. B. Rothbard, J. L. Strominger, and D. C. Wiley. 1990. Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding. EMBO J. 9:1797.
13. O'Sullivan, D., T. Arrhenius, J. Sidney, M.-F. Del Guercio, M. Albertson, M. Wall, C. Oseroff, S. Southwood, S. M. Colòn, F. C. A. Gaeta, and A. Sette. 1991. On the interaction of promiscuous antigenic peptides with different DR alleles. J. Immunol. 147:2664.
14. Geluk, A., K. E. Meijgaarden, A. A. M. Janson, J. W. Drijfhout, R. H. Meloen, R. R. P. Vries, and T. H. M. Ottenhof. 1992. Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides. J. Immunol. 149:2864.
15. Hammer, J., F. Gallazzi, E. Bono, R. W. Karr, J. Guenot, P. Valsasnini, Z. A. Nagy, and F. Sinigaglia. 1995. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J. Exp. Med. 181:1847.
16. Hammer, J., B. Takacs, and F. Sinigaglia. 1992. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J. Exp. Med. 176:1007.
17. Sette, A., J. Sidney, C. Oseroff, M.-F. del Guercio, S. Southwood, T. Arrhenius, M. F. Powell, S. M. Colon, F. C. Gaeta, and H. M. Grey. 1993. HLA DR4w4 binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J. Immunol. 151:3163.
18. Johansen, B. H., F. Vartdal, J. A. Eriksen, E. Thorsby, and L. M. Sollid. 1996. Identification of a putative motif for binding of peptides to HLA-DQ2. Int. Immunol. 8:177.
19. Hammer, J., E. Bono, F. Gallazzi, C. Belunis, Z. Nagy, and F. Sinigaglia. 1994. Precise prediction of major histocompatibility complex class II peptide interaction based on peptide side chain scanning. J. Exp. Med. 180:2353.
20. Boehncke, W. H., T. Takeshita, C. D. Pendleton, R. A. Houghten, N. Sadegh, S. Racioppi, J. A. Berzofsky, and R. N. Germain. 1993. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition. J. Immunol. 150:331.
21. Marshall, K. W., K. J. Wilson, J. Liang, A. Woods, D. Zaller, and J. B. Rothbard. 1995. Prediction of peptide affinity to HLA DRB1*0401. J. Immunol. 154:5927.
22. Reay, P. A., R. M. Kantor, and M. M. Davis. 1994. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J. Immunol. 152:3946.
23. Parker, K. C., M. A. Bednarek, and J. E. Coligan. 1994. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152:163.
24. Fugger, L., J. Rothbard, and G. Sonderstrup-McDevitt. 1996. Specificity of an HLA-DRB1*0401 restricted T cell response to type II collagen. Eur. J. Immunol. 26:928.
25. Sidney, J., C. Oseroff, M. F. del Guercio, S. Southwood, K. J. I., G. Y. Ishioka, K. Sakaguchi, E. Appella, and A. Sette. 1994. Definition of a DQ3.1-specific binding motif. J. Immunol. 152:4516.
26. Johansen, B. H., T. Jensen, C. J. Thorpe, F. Vartdal, E. Thorsby, and L. M. Sollid. 1996. Both alpha and beta chain polymorphisms determine the specificity of the disease-associated HLA-DQ molecules, with beta chain residues being most influential. Immunogenetics 45:142.
27. Kwok, W. W., M. E. Domeier, F. C. Raymond, P. Byers, and G. T. Nepom. 1996. Allele-specific motifs characterize HLA-DQ interaction with a Diabetes-associated peptide derived from glutamic acid decarboxylase. J. Immunol. 156:2171.
28. Kwok, W. W., M. E. Domeier, M. L. Johnson, G. T. Nepom, and D. M. Koelle. 1996. HLA-DQB1 codon 57 is critical for peptide binding and recognition. J. Exp. Med. 183:1253.
29. Vartdal, F., B. H. Johansen, T. Friede, C. J. Thorpe, S. Stevanovic, J. A. Eriksen, K. Sletten, E. Thorsby, H. G. Rammensee, and L. M. Sollid. 1996. The peptide binding motif of the disease-associated HLA-DQ(α1*0501,β1*0201) molecule. Eur. J. Immunol. 26:2764.
30. Van de Wal, Y., Y. M. C. Kooy, J. W. Drijfhout, R. Amons, and F. Koning. 1996. Peptide binding characteristics of the coeliac disease-associated DQ(α1*0501, β1*0201) molecule. Immunogenetics 44:246.
31. Germain, R. N. 1995. Binding domain regulation of MHC class III molecule assembly, trafficking, fate, and function. Semin. Immunol. 7:361.
32. Cammarota, G., A. Scheirle, B. Takacs, D. M. Doran, R. Knorr, W. Bannwarth, J. Guardiola, and F. Sinigaglia. 1992. Identification of a CD4 binding site on the β2 domain of HLA-DR molecules. Nature 356:799.
33. Sinigaglia, F., P. Romagnoli, M. Guttinger, B. Takacs, and J. R. L. Pink. 1992. Selection of T-cell epitopes and vaccine engineering. Methods Enzymol. 203:370.
34. Spitz, H., J. Borst, M. Giphart, J. Coligan, C. Terhorst, and J. E. De Vries. 1984. HLA-DC antigens can serve as recognition elements for human cytotoxic T lymphocytes. Eur. J. Immunol. 14:299.
35. Panina-Bordignon, P., A. Tan, A. Termijtelen, S. Demotz, G. Corradin, and A. Lanzavecchia. 1989. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol. 19:2237.
36. Rammensee, H.-G., T. Friede, and S. Stevanovic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
37. Geluk, A., K. E. Vanmeijgaarden, J. W. Drijfhout, and T. H. M. Ottenhoff. 1995. CLIP binds to HLA class II using methionine-based, allele-dependent motifs as well as allele-independent supermotifs. Mol. Immunol. 32:975.
38. Malcherek, G., V. Gnau, G. Jung, H. G. Rammensee, and A. Melms. 1995. Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules. J. Exp. Med. 181:527.
39. Sette, A., S. Southwood, J. Miller, and E. Appella. 1995. Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II. J. Exp. Med. 181:677.
40. g7, the class II MHC molecule of NOD and Biozzi AB/H mice. J. Exp. Med. 185:1013.